Cybin to acquire small pharma inc.

Toronto & london--(business wire)--cybin inc. (nyse american:cybn) (neo:cybn) (“cybin”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, and small pharma inc. (tsxv:dmt) (otcqb:dmttf) (“small pharma”), a u.k.-based biotechnology company focused on short-duration psychedelic therapies for mental health conditions, today announced that they have entered into a definitive arrangement agr.
CYBN Ratings Summary
CYBN Quant Ranking